Mark L Baum - 23 Jul 2021 Form 4 Insider Report for HARROW HEALTH, INC. (HROW)

Role: Chief Executive Officer, Director
Signature: /s/ Mark L. Baum
Issuer symbol: HROW
Transactions as of: 23 Jul 2021
Net transactions value: $0
Form type: 4
Filing time: 23 Jul 2021, 17:44:05 UTC
Next filing: 21 Jan 2022
SEC: View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HROW	Restricted Stock Unit	Award	$0	+762,301		$0.000000	762,301	23 Jul 2021	Common Stock	762,301		Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents performance-based restricted stock units ("PSUs") granted under the Issuer's 2017 Stock Incentive and Awards Plan, as amended (the "Plan"). Each PSU represents a contingent right to receive one share of common stock of the Issuer upon vesting. Vesting of the PSUs requires a minimum of a two-year service period and achievement of pre-determined total stockholder return-based performance targets ranging from a 50% - 250% increase during the term of the PSUs.

Content

Represents performance-based restricted stock units ("PSUs") granted under the Issuer's 2017 Stock Incentive and Awards Plan, as amended (the "Plan"). Each PSU represents a contingent right to receive one share of common stock of the Issuer upon vesting. Vesting of the PSUs requires a minimum of a two-year service period and achievement of pre-determined total stockholder return-based performance targets ranging from a 50% - 250% increase during the term of the PSUs.